Description
Phase
Phase 2 - takes the treatment one step further, assessing the activity of a particular therapy in a disease, often building upon leads from the Phase I trial. While patients are generally required to be previously untreated, participation in a Phase II trial doesn't usually preclude the patient from getting the standard treatment after they've received the investigational agent. At best they are allowed to get a new drug they wouldn't be able to get otherwise that may turn out to be better for their disease.Inclusion and Exclusion Criteria
Please contact Poornima Murali to learn more about the eligibility criteria for this trial. Please use the contact form on the right side.
Sites
-
California
- Unknown facility, Los Angeles, California, 90033
- Unknown facility, Los Angeles, California, 90095
- Unknown facility, Fullerton, California, 92835
- Unknown facility, Santa Barbara, California, 93105
- Unknown facility, Bakersfield, California, 93309
- Unknown facility, San Luis Obispo, California, 93454
- Unknown facility, San Luis Obispo, California, 93454
-
Nevada
- Unknown facility, Las Vegas, Nevada, 89148
- Unknown facility, Las Vegas, Nevada, 89148
-
Colorado
- Unknown facility, Aurora, Colorado, 80045
- Unknown facility, Aurora, Colorado, 80045
-
Washington
- Unknown facility, Seattle, Washington, 98109
- Unknown facility, Kirkland, Washington, 98034
-
Missouri
- Unknown facility, Jefferson City, Missouri, 65109
-
Kentucky
- Unknown facility, Paducah, Kentucky, 42003
-
Illinois
- Unknown facility, Harvey, Illinois, 60426
-
France
- Unknown facility, Villejuif, 94805
- Unknown facility, Paris, 75015
-
Germany
- Unknown facility, Stuttgart, 70199
- Unknown facility, Stuttgart, 70199
-
Veneto
- Unknown facility, Padova, Veneto, 35128
Powered by
SC CTSI